Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Halberd Corp (OP: HALB )

0.0035 +0.0001 (+2.94%)
Streaming Delayed Price Updated: 1:48 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Halberd Corp

< Previous 1 2 3 4 5 Next >
Halberd Corporation CEO Letter
Q2-21 Accomplishments and Q3 Plans JACKSON CENTER, PA / ACCESSWIRE / July 6, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC PINK: HALB) As we began the second quarter, the... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process
Method Does Not Require Antibody Conjugated Metallic Nanoparticles JACKSON CENTER, PA / ACCESSWIRE / June 30, 2021 / Halberd Corporation (OTC PINK:HALB) announces a possible breakthrough method for the... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation's Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage Process
JACKSON CENTER, PA / ACCESSWIRE / June 21, 2021 / Halberd Corporation's (OTC PINK:HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens
Enables Extracorporeal Eradication of Pathogens from Cerebral Spinal Fluid Via Radio Frequency and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / June 16, 2021 / Halberd Corporation (OTC... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease
JACKSON CENTER, PA / ACCESSWIRE / June 9, 2021 / Halberd Corporation (OTC PINK:HALB) commences experimentations to eradicate three of the principal components of Alzheimer's Disease. By eliminating... 
From Halberd Corporation
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Exposures COVID-19 Death Intellectual Property
Halberd Corporation Creates Two New and Stronger SARS-CoV-2 Neutralizing Antibodies
Demonstrates Greater Binding Affinity Than Previous Antibodies JACKSON CENTER, PA / ACCESSWIRE / June 7, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful creation of two new... 
From Halberd Corporation
Via AccessWire
Topics Animal Testing Intellectual Property Regulatory Compliance
Exposures Animal Testing COVID-19 Intellectual Property
Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects
JACKSON CENTER, PA / ACCESSWIRE / June 1, 2021 / Halberd Corporation (OTC PINK:HALB) announced the filing of a U. S. joint provisional patent application titled, "Antibody Conjugated Nanoparticle Assay... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Successfully Conjugates Metallic Particles and E. Coli Antibody
Breakthrough Achievement Enables Extracorporeal Eradication of Pathogens Via Radio Frequency Waves and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / May 25, 2021 / Halberd Corporation (OTC... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19
JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Reports Successful Conjugation of Metallic Particles & SARS-CoV-2 Proprietary Monoclonal Antibody
JACKSON CENTER, PA / ACCESSWIRE / May 17, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful conjugation of gold-coated iron nanoparticles with Halberd's patent-pending monoclonal... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Begins Testing of Patented Process for Laser Eradication of Disease
JACKSON CENTER, PA / ACCESSWIRE / May 13, 2021 / Halberd Corporation (OTC PINK:HALB) announces the commencement of its patented extra-corporeal process experimentation using lasers to eradicate... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications
JACKSON CENTER, PA / ACCESSWIRE / May 10, 2021 / Halberd Corporation (OTC PINK:HALB) was recently discussed in Penny Stocks News and Wall Street Trader publications as a BREAKOUT stock to watch with a... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease
JACKSON CENTER, PA / ACCESSWIRE / May 4, 2021 / Halberd Corporation (OTC PINK:HALB) announces the appointment of Dr. Mitchell S. Felder, previously a consultant to Halberd Corporation, to the position... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser
JACKSON CENTER, PA / ACCESSWIRE / April 26, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, "Treating... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations
JACKSON CENTER, PA / ACCESSWIRE / April 21, 2021 / Halberd Corporation's (OTC PINK:HALB) two patent-pending monoclonal antibodies have demonstrated strong affinity and neutralizing capabilities against... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Moves Radio Frequency (RF) Disease Elimination Effort Forward with the Addition of Youngstown State University (YSU) and Dr. William G. Sturrus
Brings Critical Radio Frequency Wave Expertise to Company's Effort JACKSON CENTER, PA / ACCESSWIRE / April 19, 2021 / Halberd Corporation (OTC PINK:HALB) is pleased to announce Youngstown State... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment
JACKSON CENTER, PA / ACCESSWIRE / April 12, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, "Covid-19... 
From Halberd Corporation
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.